글로벌 Hallux Valgus 치료 시장 – 2029년까지의 산업 동향 및 예측

시장 분석 및 규모

최근 몇 년 동안, 외반증 치료 시장은 빠르게 성장할 것으로 추정됩니다. 라이프스타일의 변화와 직장 여성 인구의 증가 때문입니다. 이로 인해 외반증 위험이 높아지고 예측 기간 동안 외반증 치료 시장 수요가 가속화됩니다. 외반증은 관절염과도 관련이 있으며, 관절염은 관절의 연골을 악화시킵니다. 외반증 치료 시장은 일반 인구에서 흔하며, 18~65세 성인의 23%, 65세 이상의 35.7%가 외반증을 앓고 있습니다. 일반적으로 여성의 유병률이 남성보다 높습니다.

• 가장 흔한 발 이상은 외반모지입니다. 이것은 제1 중족지절(MTP) 관절에 영향을 미치는 퇴행성 발 기형으로, 상당한 기능 장애, 발 통증 및 낮은 생활 수준을 초래합니다. 외반모지에 가해지는 압력을 완화하는 외반모지 보호대 또는 패드를 사용하는 것은 치료의 일부입니다. 발의 구조와 외반모지의 심각도에 따라 맞춤형 깔창 보조 장치를 생산할 수 있습니다. 이러한 깔창을 사용하면 외반모지 진행을 늦출 수 있습니다. 브레이싱은 브레이스를 사용하는 수술 후 재활 요법의 한 유형입니다.
• Data Bridge Market Research에 따르면, 외반모지 치료 시장은 2022년부터 2029년까지의 예측 기간 동안 연평균 성장률 7.00%로 성장할 것으로 예상됩니다.

Hallux Valgus 치료 시장 동향

운전자

• 뼈질환 발생률이 높다

뼈 질환의 발병률 증가는 시장 성장률 확대로 이어질 주요 원동력으로 작용할 것입니다. 여성은 일반적으로 뾰족한 하이힐을 신으므로, 여성에게 남성보다 외반족이 더 흔하다는 것이 밝혀졌습니다. 그 결과 발의 내재적 및 외재적 연조직이 부러지거나 불균형을 이루게 되어 뼈 질환의 가능성이 높아지고 외반족 치료 시장이 앞으로 나아갈 것입니다.

• 의료 인프라에 대한 투자 증가

외반족 치료 시장의 성장률에 영향을 미치는 또 다른 중요한 요인은 의료 서비스 지출이 증가하고 있다는 점인데, 이는 인프라 개선에 도움이 됩니다.

• 염증성 질환의 유병률 증가

류마티스 관절염 과 같은 염증성 질환의 유병률 증가는 외반족 변형의 위험을 증가시킬 것이며, 이로 인해 치료 시장의 성장률이 촉진될 것입니다.   

Furthermore, rising initiatives by public and private organizations to spread awareness and growing demand for effective therapies are the factors that will expand the hallux valgus treatment market. Other factors such as continuous changing lifestyle coupled with increasing number of working women population will positively impact the hallux valgus treatment market's growth rate. Additionally, high disposable income and a rising geriatric population will result in the expansion of the hallux valgus treatment market. 

Opportunities

• Rise in the investments and research funding for hallux valgus treatment will flourish the growth rate

Moreover, the rise in level of investments and funds for research and development activities will boost new opportunities for the market's growth rate.

Also, a surging number of strategic partnerships with various public and private organizations to develop treatment solutions for hallux valgus treatment and availability of cost-effective drugs will provide beneficial opportunities for the hallux valgus treatment market in the forecast period of 2022-2029.

Restraints/Challenges

However, high cost associated with the surgical treatment and lack of infrastructure in low-income countries will impede the growth rate of the hallux valgus treatment market. Additionally, the dearth of novel treatment and strict FDA regulatory guidelines linked with the approval of medical devices will hinder the hallux valgus treatment market growth. The emergence of unfavourable conditions due to COVID-19 outbreak and less awareness in patients will further challenge the market in the forecast period mentioned above.

This hallux valgus treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on hallux valgus treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Hallux valgus (H.V.) deformity is a very common ailment. It affects about 23% of adults between the ages of 18 and 65, and up to 36% of adults over 65. When it comes to adult females, H.V. malformation can be as high as 30%. Compared to the barefoot population, people who wear shoes or heels have a higher prevalence. When women and men in barefoot populations are compared, women are twice as likely to suffer hallux valgus deformity.

Hallux valgus treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Hallux Valgus Treatment Market

Since its emergence in December 2019, the COVID-19 virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. Due to the financial crisis and the delay in specialty healthcare delivery while prioritizing COVID-19-related treatments, healthcare systems worldwide have been severely disrupted in the aftermath of the coronavirus pandemic. Patients were unable to see their controls for various reasons, including difficulty accessing a doctor, fear of infection transmission, inability to continue therapies and essential procedures due to pandemic restrictions. Such considerations may have a negative impact on the market of hallux valgus treatment in recent months.

Recent Development

• In May 2021, Heron Therapeutics, Inc. announced the U.S. Food and Drug Administration (FDA) approval for Zynrelef. It is an extended-release dual-acting local anaesthetic of bupivacaine and meloxicam for pain management.

Global Hallux Valgus Treatment Market Scope

The hallux valgus treatment market is segmented on the basis of type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Congenital Hallux Valgus
• Juvenile or Adolescent Hallux Valgus
• Tailor's Bunion

On the basis of type, the hallux valgus treatment market is segmented into congenital hallux valgus, juvenile or adolescent hallux valgus, and tailor's bunion.

Treatment

• Medications
• Self-Care
• Devices
• Surgery
• Medical Procedures

On the basis of treatment, the hallux valgus treatment market is segmented into medications, self-care, devices, surgery and medical procedures. The medication is sub-segmented into analgesic and non-steroidal anti-inflammatory drug. The self-care is segmented into wide shoes, cold compress, and bunion pads. The device is segmented into braces. The medical procedure is divided into callus shaving and the surgery is classified into bone surgery. Furthermore, the bone surgery is classified into different types including distal chevron osteotomy, scarf or ludloff osteotomy, crescent osteotomy, and lapidus procedure.

Diagnosis

• X-Rays
• Medical History
• Physical Examination
• Radiography
• Others

On the basis of diagnosis, the hallux valgus treatment market is segmented into medical history, X-rays, radiography, physical examination and others.

Dosage

• Injection
• Tablets
• Others

On the basis of dosage, the hallux valgus treatment market is segmented into injection, tablets, ointments and others.

Route of Administration

• Oral
• Parenteral
• Others

On the basis of route of administration, the hallux valgus treatment market is segmented into oral, parenteral, topical and others.

End Use

• Clinic
• Hospital
• Others

On the basis of end-users, the hallux valgus treatment market is segmented into clinic, hospital and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

The hallux valgus treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Hallux Valgus Treatment Market Regional Analysis/Insights

The hallux valgus treatment market is analysed and market size insights and trends are provided by country, type, treatment, diagnosis, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the hallux valgus treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

America dominates the hallux valgus treatment market in terms of market share and revenue and will continue to flourish its dominance during the forecast period. This is due to the presence of major key players, trendy lifestyle attained by women's and rise in merger and acquisition in this region.

Europe on the other hand is projected to exhibit the highest growth rate during the forecast period due to the rising healthcare expenditure and technological advancement in this region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

경쟁 환경 및 Hallux Valgus 치료 시장 점유율 분석

할럭스 발거스 치료 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 응용 분야 우위가 있습니다. 제공된 위의 데이터 포인트는 할럭스 발거스 치료 시장과 관련된 회사의 초점에만 관련이 있습니다.

외반모지 치료 시장의 주요 기업으로는 Smith+Nephew, Arthrex, Inc., Wright Medical Group NV, Biocon, Custopharm, Inc., Novartis AG, Sanofi, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma, Fresenius Kabi AG, Stryker, Zimmer Biomet, Integra LifeSciences, Össur, Acumed LLC, Extremity Medical, Johnson & Johnson Private Limited, BioPro, Inc., Orthofix Medical Inc., MONDEAL Medical Systems GmbH, Pfizer Inc., GlaxoSmithKline plc, Bayer AG, Reckitt Benckiser Group PLC, Assertio Holdings, Inc. 등이 있습니다.

SKU-52524